Vacquinol-1 dihydrochloride
SIGMA/SML1187 - ≥98% (HPLC)
Synonym: 2-(4-Chlorophenyl)-α−2-piperidinyl-4-quinolinemethanol dihydrochloride; NSC13316
CAS Number: 5428-80-8 (free base)
Empirical Formula (Hill Notation): C21H21ClN2O · 2HCl
Molecular Weight: 425.78
Linear Formula: C21H21ClN2O · 2HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C21H21ClN2O/c22-15-10- |
| InChI key | VKLJPGAHSLIQKH-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Clc1ccc(cc1)c2nc3c(c(c2)C |
| solubility | DMSO: 5 mg/mL, clear (warmed) |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Vacquinol-1 (NSC13316) is a brain penetrant inducer of catastrophic vacuolization in glioblastoma cells (GCs). Vacquinol-1 displays high cytotoxicity to GCs; it induces cell death by membrane ruffling, cell rounding, massive macropinocytic vacuole accumulation, ATP depletion, and cytoplasmic membrane rupture of GCs. Vacquinol-1 originally was developed as an antimalarial compound. |
| Biochem/physiol Actions: | Vacquinol-1 dihydrochloride is potentially used as a therapeutic for Glioblastoma multiforme (GBM). This drug is highly stable in vivo, with a half-life in plasma of 52 hour. Vacquinol-1 has high oral bioavailability and good brain penetration. |
| Biochem/physiol Actions: | Vacquinol-1 is a brain penetrant inducer of catastrophic vacuolization in glioblastoma cells. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

